Patents by Inventor RANBAXY LABORATORIES LIMITED

RANBAXY LABORATORIES LIMITED has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130216619
    Abstract: The present invention relates to an oral pharmaceutical composition comprising: a) a core comprising atorvastatin or a pharmaceutically acceptable salt thereof and an alkalizing agent; b) an intermediate coating over the core; and c) an outer coating comprising ezetimibe.
    Type: Application
    Filed: February 13, 2013
    Publication date: August 22, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventor: Ranbaxy Laboratories Limited
  • Publication number: 20130195973
    Abstract: The present invention relates to an extended-release pharmaceutical dosage form of carbidopa and levodopa comprising (i) an immediate-release unit of carbidopa and levodopa; (ii) an extended-release unit of carbidopa and levodopa; and (iii) an immediate or extended-release unit of a carboxylate salt. The present invention further provides a process of preparation thereof.
    Type: Application
    Filed: January 29, 2013
    Publication date: August 1, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventor: RANBAXY LABORATORIES LIMITED
  • Publication number: 20130190337
    Abstract: The present invention relates to a solid dosage form comprising a solid dispersion composition of at least one HIV protease inhibitor and a water-soluble polymer having a glass transition temperature (Tg) of at least about 50° C. in an amount of less than 50% by weight of the dosage form. It also relates to a process of preparation for such solid dosage forms.
    Type: Application
    Filed: March 7, 2013
    Publication date: July 25, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventor: RANBAXY LABORATORIES LIMITED